SL
DGX icon

Savior LLC’s Quest Diagnostics DGX Stock Holding History

Savior LLC’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-29
Closed -$4K – 339
2021
Q2 		$4K Sell
29
-45
-61% -$5.89K ﹤0.01% 605
2021
Q1 		$9K Hold
74
– – 0.01% 434
2020
Q4 		$9K Sell
74
-69
-48% -$8.41K 0.01% 422
2020
Q3 		$16K Hold
143
– – 0.02% 287
2020
Q2 		$16K Hold
143
– – 0.02% 266
2020
Q1 		$11K Sell
143
-4
-3% -$414 0.01% 303
2019
Q4 		$16K Buy
+147
New +$15.3K 0.02% 337

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Savior LLC's DGX Position: Q3 2021 in Review

Savior LLC sold out of Quest Diagnostics (DGX) in Q3 2021, closing a stake of 29 shares — an estimated $4K sold.

Savior LLC first reported a position in DGX in Q4 2019 and held it in 7 quarters. The position peaked at $16K in Q3 2020. 837 funds tracked by Wall St. Rank hold DGX as of Q3 2021.

  • Savior LLC reported no remaining Quest Diagnostics position as of Q3 2021 after selling out during the quarter.
  • Savior LLC sold 29 Quest Diagnostics shares in Q3 2021, an estimated $4K.
  • Savior LLC first reported a position in Quest Diagnostics in Q4 2019 and held it in 7 quarters.
  • Savior LLC's Quest Diagnostics position peaked at $16K in Q3 2020.
  • 837 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2021.

Based on Savior LLC's 13F filing for Q3 2021, filed 5 Oct 2021.